Aclarion (ACON) Research & Development (2021 - 2026)

Aclarion (ACON) has reported Research & Development for 6 consecutive years, with $877160.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 155.16% year-over-year to $877160.0; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (up 149.85% YoY), and the FY2025 full-year result was $1.9 million, up 94.62% from the prior year.
• Research & Development slipped to $877160.0 in Q2 2026 per ACON's latest filing, from $908797.0 in the prior quarter.
• Across five years, Research & Development topped out at $908797.0 in Q1 2026 and bottomed at $198252.0 in Q3 2023.
• Historically, Research & Development has averaged $370134.5 across 5 years, with a median of $270486.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Research & Development tumbled 31.86% in 2023, then jumped 200.35% in 2026.
• Over 5 years, Research & Development stood at $218997.0 in 2022, then grew by 0.77% to $220679.0 in 2023, then surged by 53.02% to $337685.0 in 2024, then jumped by 84.15% to $621839.0 in 2025, then jumped by 41.06% to $877160.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $877160.0, $908797.0, and $621839.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.